Related Experiment Video
Updated: Apr 15, 2026
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Oncology: What You May Have Missed in 2025
Mobolaji Adeolu1, Jennifer Ehiwario1, Melody Aida Emamian1
1Department of Medical Oncology, McMaster University, Hamilton, Ontario, Canada (M.A., J.E., M.A.E.).
Abstract:
Oncology care increasingly necessitates collaboration with physicians in other specialties. This article highlights 10 studies published in 2025 that we believe are important for nononcologists who participate in the care of patients with cancer. The articles selected provide updates on advancements that influence the full spectrum of oncology care. Several studies present therapeutic developments for lung, colorectal, and breast cancer. A major theme of the 2025 literature is evidence-based de-escalation, including reducing mammographic surveillance in older breast cancer survivors and omitting autologous stem cell transplant in patients with multiple myeloma who achieve measurable residual disease negativity. Another study addresses reduced-dose apixaban for extended cancer-associated thrombosis management and the validation of elinzanetant for nonhormonal management of vasomotor symptoms. These studies collectively move the field toward highly personalized, biomarker-driven interventions that require integrated care models to optimize patient outcomes.
Insights
This review covers 2025 oncology research for non-oncologists, emphasizing de-escalation strategies and personalized treatments for lung, colorectal, and breast cancers. It highlights advancements in cancer care and integrated models for better patient outcomes.
Area of Science:
- Oncology
- Internal Medicine
- Evidence-Based Medicine
Background:
- Oncology care requires increasing interdisciplinary collaboration.
- Non-oncologists play a crucial role in managing cancer patients.
- Keeping abreast of the latest oncology advancements is vital for comprehensive patient care.
Purpose of the Study:
- To highlight 10 key studies from 2025 relevant to non-oncologists treating cancer patients.
- To provide updates on advancements across the spectrum of oncology care.
- To emphasize the trend towards personalized, biomarker-driven interventions.
Main Methods:
- Review of 10 selected studies published in 2025.
- Focus on therapeutic developments and evidence-based de-escalation strategies.
- Inclusion of studies on specific cancers (lung, colorectal, breast) and supportive care.
Main Results:
- Therapeutic advancements in lung, colorectal, and breast cancer.
- Evidence-based de-escalation strategies, such as reduced mammographic surveillance and omitting stem cell transplants.
- Optimized management of cancer-associated thrombosis and vasomotor symptoms.
Conclusions:
- The 2025 literature signifies a shift towards personalized, biomarker-driven oncology care.
- Integrated care models are essential for optimizing patient outcomes.
- De-escalation strategies represent a significant trend in modern cancer management.
More Related Videos
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:59Cancer Prevention
02:59Cancer Prevention
Some...